Virax Biolabs Group Limited
VRAX
NASDAQ1.47
USD
+0.07
- -
Total Valuation
Virax Biolabs Group Limited carries a market capitalization of 1.97M, placing it among publicly traded companies globally.
| Market Cap | 1.97M |
| Enterprise Value | N/A |
Stock Price Statistics
Virax Biolabs Group Limited's stock has declined approximately -91.08338% over the past 52 weeks. The 50-day moving average sits at 2.49, while the 200-day moving average is 4.27.
| Beta (5Y) | N/A |
| 52-Week Price Change | -91.08338% |
| 50-Day Moving Average | 2.49 |
| 200-Day Moving Average | 4.27 |
| Average Volume (20 Days) | N/A |
Stock Splits
Virax Biolabs Group Limited's most recent stock split took place on June 26, 2026 with a 25:1 split ratio.
| Last Split Date | 6/26/2026 |
| Split Ratio | 25:1 |